![]() ![]() regulators recently issued emergency use authorizations for new bivalent boosters for the Moderna and Pfizer Covid-19 vaccines to protect against the Omicron subvariants of the virus, scientists are still working to test different COVID-19 vaccines to see if they can deliver more durable and longer-lasting protection. The trial, performed at the Tulane National Primate Research Center, tested a vaccine that is currently in use in South Korea, but not yet available outside the country. ![]() The study, led by principal investigator Bali Pulendran, PhD, of Stanford University and published in Science Translational Medicine, evaluated the vaccine’s performance over time in nonhuman primates. Illustration by iStock.Ī recent study co-authored by Tulane University researchers shows a new COVID-19 vaccine offers longer-lasting protection against Omicron variants of SARS-CoV-2. The study showed significant respiratory protection against Omicron subvariants of the SARS-CoV-2 virus lasting at least six months. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |